Hotbed/Location
Filter News
Found 736,910 articles
-
LifeCycle Pharma Appoints New President and CEO; Executive Vice President and CFO Resigns
10/17/2008
-
Milkshake Study Reveals Brain's Role In Obesity, Oregon Research Institute Reports
10/17/2008
-
Protein Shown To Play A Key Role In Normal Development Of Nervous System, Children's Hospital of Philadelphia Study
10/17/2008
-
Disinfectants Can Boost Bacteria's Resistance to Treatment, Department of Veterans Affairs Medical Center Study
10/17/2008
-
Genentech's (JOBS) Psoriasis Drug Raptiva Gets FDA Warning
10/17/2008
-
Daiichi Sankyo Co Ltd. and Eli Lilly and Company New Drug Still on Track
10/17/2008
-
Pfizer Inc. (JOBS) to Pay $894 Million to Resolve Celebrex, Bextra Lawsuits
10/17/2008
-
CeNeRx BioPharma, Inc. Completes $15 Million Series B Financing
10/17/2008
-
University of Iowa Study Finds Value In 'Junk' DNA
10/17/2008
-
Pozen, Inc. Says FDA Reviewing Main Goal of Trials
10/17/2008
-
British Association of Dermatologists Doctors Warn Of Rash From Mobile Phone Use
10/17/2008
-
Brazilian Acai Berry Antioxidants Absorbed By Human Body, University of Texas Research Shows
10/17/2008
-
'OPEN I' Study Demonstrates Safety of the Stentys Stent at 30-day Follow-up of 40 Patients
10/17/2008
-
Biosyntech Inc. Announces Resignation of CEO and Appointment of New Board Member
10/17/2008
-
$22 Million Biomanufacturing Plant Completed for CEL-SCI
10/17/2008
-
FDA Advisory Panel to Discuss Genzyme Corporation’s Myozyme BLA on Tuesday
10/17/2008
-
Pozen, Inc. Confirms ANDA Filing for Treximet(R) Tablets By Par Pharmaceutical, Inc.
10/17/2008
-
Novo Nordisk A/S New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes
10/17/2008
-
Alexza Pharmaceuticals, Inc. Completes Enrollment in Second Phase 3 Clinical Trial With AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10/17/2008
-
Aeras Global TB Vaccine Foundation and Crucell N.V. Announce TB Vaccine Clinical Trial in Kenya; Promising Vaccine Candidate Advances to Phase II Safety Study in South Africa
10/17/2008